A phase II study of TAK-272 for early stage diabetic nephropathy and/or hypertension
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Imarikiren (Primary)
- Indications Diabetic nephropathies; Hypertension
- Focus Therapeutic Use
- 15 Mar 2017 New trial record